Our results confirmed the clinical relevance of PSMD14-mediated regulation of CARM1 in HCC, suggesting that the upregulation of CARM1 and PSMD14 may hold promise as prognostic indicators for patients with HCC. The gene discussed is CARM1; the disease is hepatocellular carcinoma.